These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 11835386)

  • 1. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
    van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC
    Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
    Pronk JC; Leegwater PA; van der Knaap MS
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
    Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
    Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
    Pan YX; Wu Y; Niu ZP; Jiang YW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways.
    Li W; Wang X; Van Der Knaap MS; Proud CG
    Mol Cell Biol; 2004 Apr; 24(8):3295-306. PubMed ID: 15060152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukoencephalopathy with vanishing white matter: a review.
    Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
    Wortham NC; Proud CG
    BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The large spectrum of eIF2B-related diseases.
    Fogli A; Boespflug-Tanguy O
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eIF2B: recent structural and functional insights into a key regulator of translation.
    Wortham NC; Proud CG
    Biochem Soc Trans; 2015 Dec; 43(6):1234-40. PubMed ID: 26614666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
    Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
    Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of ovarioleukodystrophy without eIF2B mutations.
    Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
    J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF2B-related disorders: antenatal onset and involvement of multiple organs.
    van der Knaap MS; van Berkel CG; Herms J; van Coster R; Baethmann M; Naidu S; Boltshauser E; Willemsen MA; Plecko B; Hoffmann GF; Proud CG; Scheper GC; Pronk JC
    Am J Hum Genet; 2003 Nov; 73(5):1199-207. PubMed ID: 14566705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity.
    Richardson JP; Mohammad SS; Pavitt GD
    Mol Cell Biol; 2004 Mar; 24(6):2352-63. PubMed ID: 14993275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells.
    Sekine Y; Zyryanova A; Crespillo-Casado A; Amin-Wetzel N; Harding HP; Ron D
    PLoS One; 2016; 11(11):e0166278. PubMed ID: 27812215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes.
    Leegwater PA; Pronk JC; van der Knaap MS
    J Child Neurol; 2003 Sep; 18(9):639-45. PubMed ID: 14572143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing white matter.
    van der Knaap MS; Bugiani M; Abbink TEM
    Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanishing white matter disease: a review with focus on its genetics.
    Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS
    Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.